Supporting collaboration between the Welsh NHS and the pharmaceutical industry
Webinar showcasing collaborative working in Wales and practical support following the Welsh NHS Confed & ABPI joint partnership working guidance.
Speakers
Chair:
- Jonathan Morgan, Chair, Welsh NHS Confederation
Speakers:
- Nabil Rastani, Strategic Partnership Policy Manager, ABPI
- Stephen Tune, Regional Access Manager, Daiichi-Sankyo
- Dr Vasim Farooq, Consultant Cardiologist, Cardiff and Vale University Health Board
- Sian Morgan, Head of Laboratory at NHS Wales, All Wales Medical Genomics Service
Partnerships between the NHS and the pharmaceutical industry are essential - not only for delivering faster access to life-changing treatments, but also for unlocking expertise, capacity and innovation.
Following the publication of the Welsh NHS Confederation and the Association of the British Pharmaceutical Industry (ABPI) joint guidance, this webinar will showcase existing collaborative working in Wales and offer practical ideas to help organisations develop, implement and evaluate partnerships to improve patient outcomes.
Partnerships showcased include:
- The Cardiff and Vale Post Coronary Revascularisation Lipid Optimisation Service Collaborative Working Project (CWP), a secondary prevention CVD Collaborative Working Project, between CAVUHB, Novartis, Amgen, Recordati and Daiichi Sankyo, aiming for better patient outcomes, improved equity and access to services.
- QuicDNA project, an initiative aimed at revolutionising lung cancer diagnosis and treatment, recognised for its innovative approach and transformative impact on healthcare in Wales. Funders included: Health and Care Research Wales, AstraZeneca, Moondance Initiative, Illumina, Amgen, Lilly, and Bayer.
Cefnogi cydweithio rhwng GIG Cymru a'r diwydiant fferyllol
Dydd Mawrth 16 Rhagfyr 2025, 10.30 – 11.30
Cadeirydd:
- Jonathan Morgan, Cadeirydd, Conffederasiwn GIG Cymru
Siaradwyr:
- Nabil Rastani, Rheolwr Polisi Partneriaeth Strategol, ABPI
- Stephen Tune, Rheolwr Mynediad Rhanbarthol, Daiichi-Sankyo
- Dr Vasim Farooq, Cardiolegydd Ymgynghorol, Bwrdd Iechyd Prifysgol Caerdydd a'r Fro
- Dr Sian Morgan, Pennaeth Labordy GIG Cymru, Gwasanaeth Genomeg Feddygol Cymru Gyfan
Mae partneriaethau rhwng y GIG a’r diwydiant fferyllol yn hanfodol - nid yn unig ar gyfer rhoi mynediad cyflymach at driniaethau sy’n newid bywydau, ond hefyd ar gyfer datgloi arbenigedd, capasiti ac arloesedd.
Yn dilyn cyhoeddi canllawiau ar y cyd Conffederasiwn GIG Cymru a Chymdeithas Diwydiant Fferyllol Prydain (ABPI), bydd y weminar hon yn arddangos cydweithio presennol yng Nghymru. Bydd hefyd yn cynnig syniadau ymarferol i helpu sefydliadau i ddatblygu, gweithredu a gwerthuso partneriaethau i wella canlyniadau i gleifion.
Mae'r partneriaethau a ddangoswyd yn cynnwys:
- Prosiect Gweithio ar y Cyd (CWP) Gwasanaeth Optimeiddio Lipidau Ailfasgwleiddio Ôl-goronaidd Caerdydd a'r Fro, Prosiect Cydweithredol atal eilaidd ar gyfer CVD, rhwng BIPCF, Novartis, Amgen, Recordati a Daiichi Sankyo, gyda'r nod o wella canlyniadau cleifion, gwell tegwch a mynediad at wasanaethau.
- Prosiect QuicDNA, menter sydd â'r nod o chwyldroi diagnosis a thriniaeth canser yr ysgyfaint, wedi'i chydnabod am ei dull arloesol a'i heffaith drawsnewidiol ar ofal iechyd yng Nghymru. Roedd y cyllidwyr yn cynnwys: Ymchwil Iechyd a Gofal Cymru, AstraZeneca, Moondance Initiative, Illumina, Amgen, Lilly, a Bayer.
